Skip to Main Content

Paper Details

Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.
Blood Adv
7
2021
Author NameAffiliation
Stefan KubicekCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph Driessen
Jing TangUniversity of Helsinki
  • 1 - 3

Datasets

Release 1.2